CRISPR and other new technologies are opening the doors to drug development, but which diseases are prioritized? Depends on money and science
Prescription drugs and vaccines have revolutionized healthcare, significantly reducing deaths from disease and improving quality of life worldwide. So how do researchers, universities, hospitals, and the pharmaceutical industry decide which diseases to try to develop drugs for? Working as director of the Health Outcomes, Policy, and Evidence Synthesis group at the University of Connecticut School… Read More »